0001161697-23-000200.txt : 20230330 0001161697-23-000200.hdr.sgml : 20230330 20230330170051 ACCESSION NUMBER: 0001161697-23-000200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230328 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANDE ALICIA CENTRAL INDEX KEY: 0001402652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 23781537 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 03-28-2023 X0407 4 2023-03-28 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402652 GRANDE ALICIA 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 VP, Treasurer and CFO 0 Common stock, par value $0.001 per share 2023-03-28 4 M 0 58216 0.79 A 108773 D Common stock, par value $0.001 per share 2023-03-28 4 S 0 28216 16.60 D 80557 D Common stock, par value $0.001 per share 2023-03-28 4 S 0 10000 16.55 D 70557 D Common stock, par value $0.001 per share 2023-03-28 4 S 0 10000 16.52 D 60557 D Common stock, par value $0.001 per share 2023-03-28 4 S 0 10000 16.37 D 50557 D Common stock, par value $0.001 per share 2023-03-29 4 M 0 50000 1.13 A 100557 D Common stock, par value $0.001 per share 2023-03-29 4 S 0 20000 16.72 D 80557 D Common stock, par value $0.001 per share 2023-03-29 4 S 0 20000 16.70 D 60557 D Common stock, par value $0.001 per share 2023-03-29 4 S 0 10000 16.67 D 50557 D Options to purchase common stock 0.79 2023-03-28 4 M 0 58216 0 D 2023-06-15 Common Stock 58216 1345834 D Options to purchase common stock 1.13 2023-03-29 4 M 0 50000 0 D 2024-01-03 Common Stock 50000 1295834 D Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company. Options vested in two annual tranches beginning on June 15, 2017. Options vested in three annual tranches beginning on January 3, 2018. /s/ Alicia Grande 2023-03-30